Literature DB >> 35855062

A low proportion of asymptomatic COVID-19 patients with the Delta variant infection by viral transmission through household contact at the time of confirmation in Ibaraki, Japan.

Tsuyoshi Ogata1, Hideo Tanaka2, Fujiko Irie3, Yumiko Nozawa1, Etsuko Noguchi1, Kayoko Seo1, Emiko Tanaka1.   

Abstract

We conducted a study to investigate the proportion of patients with asymptomatic coronavirus disease 2019 (COVID-19) infected with the Delta variant compared with those infected with the wild-type strain at the time of confirmation. A total of 504 patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by viral transmission through household contact in Ibaraki, Japan were included. The proportion of asymptomatic COVID-19 patients at the time of confirmation was compared between patients infected with L452R mutation strain from June to September 2021 and those infected with the wild-type strain from November 2020 to January 2021, and was found to be 14.2% and 28.8%, respectively (relative risk, 0.49; 95% confidence interval, 0.35-0.70). The proportion of asymptomatic COVID-19 patients by viral transmission through household contact was lower among the Delta variant than those among the wild-type strain at the time of confirmation. It might contribute to attenuation of transmission. 2022, National Center for Global Health and Medicine.

Entities:  

Keywords:  Delta variant; Japan; asymptomatic; coronavirus disease 2019 (COVID-19)

Year:  2022        PMID: 35855062      PMCID: PMC9243404          DOI: 10.35772/ghm.2021.01116

Source DB:  PubMed          Journal:  Glob Health Med        ISSN: 2434-9186


  9 in total

1.  [Transmission of SARS-CoV-2 through contact with a SARS-CoV-2-infected individual in the presymptomatic or asymptomatic state in Japan: A case series].

Authors:  Hideo Tanaka; Tsuyoshi Ogata; Kazutoshi Morisada; Shinji Tanaka; Takanori Yoshida; Hiroko Nakanishi; Akiko Misawa; Toshihide Nishida; Osamu Tetsu; Manami Nagata; Eisuke Nakazato
Journal:  Nihon Koshu Eisei Zasshi       Date:  2021-05-14

2.  Asymptomatic Cases, the Hidden Challenge in Predicting COVID-19 Caseload Increases.

Authors:  Brett Snider; Bhumi Patel; Edward McBean
Journal:  Infect Dis Rep       Date:  2021-04-09

3.  Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.

Authors:  Xianding Deng; Miguel A Garcia-Knight; Mir M Khalid; Venice Servellita; Candace Wang; Mary Kate Morris; Alicia Sotomayor-González; Dustin R Glasner; Kevin R Reyes; Amelia S Gliwa; Nikitha P Reddy; Claudia Sanchez San Martin; Scot Federman; Jing Cheng; Joanna Balcerek; Jordan Taylor; Jessica A Streithorst; Steve Miller; Bharath Sreekumar; Pei-Yi Chen; Ursula Schulze-Gahmen; Taha Y Taha; Jennifer M Hayashi; Camille R Simoneau; G Renuka Kumar; Sarah McMahon; Peter V Lidsky; Yinghong Xiao; Peera Hemarajata; Nicole M Green; Alex Espinosa; Chantha Kath; Monica Haw; John Bell; Jill K Hacker; Carl Hanson; Debra A Wadford; Carlos Anaya; Donna Ferguson; Phillip A Frankino; Haridha Shivram; Liana F Lareau; Stacia K Wyman; Melanie Ott; Raul Andino; Charles Y Chiu
Journal:  Cell       Date:  2021-04-20       Impact factor: 41.582

4.  Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China.

Authors:  Yaping Wang; Ruchong Chen; Fengyu Hu; Yun Lan; Zhaowei Yang; Chen Zhan; Jingrong Shi; Xizi Deng; Mei Jiang; Shuxin Zhong; Baolin Liao; Kai Deng; Jingyan Tang; Liliangzi Guo; Mengling Jiang; Qinghong Fan; Meiyu Li; Jinxin Liu; Yaling Shi; Xilong Deng; Xincai Xiao; Min Kang; Yan Li; Weijie Guan; Yimin Li; Shiyue Li; Feng Li; Nanshan Zhong; Xiaoping Tang
Journal:  EClinicalMedicine       Date:  2021-09-12

5.  Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.

Authors:  Hiam Chemaitelly; Patrick Tang; Mohammad R Hasan; Sawsan AlMukdad; Hadi M Yassine; Fatiha M Benslimane; Hebah A Al Khatib; Peter Coyle; Houssein H Ayoub; Zaina Al Kanaani; Einas Al Kuwari; Andrew Jeremijenko; Anvar H Kaleeckal; Ali N Latif; Riyazuddin M Shaik; Hanan F Abdul Rahim; Gheyath K Nasrallah; Mohamed G Al Kuwari; Hamad E Al Romaihi; Adeel A Butt; Mohamed H Al-Thani; Abdullatif Al Khal; Roberto Bertollini; Laith J Abu-Raddad
Journal:  N Engl J Med       Date:  2021-10-06       Impact factor: 91.245

6.  Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021.

Authors:  Finlay Campbell; Brett Archer; Henry Laurenson-Schafer; Yuka Jinnai; Franck Konings; Neale Batra; Boris Pavlin; Katelijn Vandemaele; Maria D Van Kerkhove; Thibaut Jombart; Oliver Morgan; Olivier le Polain de Waroux
Journal:  Euro Surveill       Date:  2021-06

7.  Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.

Authors:  Joel Hellewell; Sam Abbott; Amy Gimma; Nikos I Bosse; Christopher I Jarvis; Timothy W Russell; James D Munday; Adam J Kucharski; W John Edmunds; Sebastian Funk; Rosalind M Eggo
Journal:  Lancet Glob Health       Date:  2020-02-28       Impact factor: 26.763

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.